Democratic participants of the house Oversight Committee referred to as on Chairman Jason Chaffetz Wednesday morning to hold a hearing with J. Michael Pearson of Valeant prescribed drugs VRX, -14.36% and Martin Shkreli of Turing prescription drugs to research the dramatic worth will increase of some prescribed drugs. In a letter to Chaffetz the participants asked Chaffetz to not stand in the way in which of issuing subpoenas to the two males. Executives at each companies have rejected earlier requests to Pearson and Shkreli from rating member Democrat Elijah Cummings to provide details about the price will increase. questions about Valeant and Turing received more importance after numerous recent press reviews raised severe new issues about the industry practices of both corporations and their business companions.
This entry handed during the Full-textual content RSS carrier – if this is your content material and you are studying it on anyone else’s website, please read the FAQ at fivefilters.org/content material-most effective/faq.php#publishers.
Facebook
Twitter
Instagram
Google+
LinkedIn
RSS